The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

The aim of this new statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …

Background The prevalence of patent foramen ovale among patients with cryptogenic stroke
is higher than that in the general population. Closure with a percutaneous device is often …

Background Patent foramen ovale and atrial septal aneurysm have been identified as
potential risk factors for stroke, but information about their effect on the risk of recurrent …

Background—Patent foramen ovale (PFO) is associated with stroke, but there are no
randomized studies to evaluate the efficacy of antithrombotic therapies. Methods and …

Background We conducted a systematic review and meta‐analysis of randomized controlled
trials (RCT s) comparing patent foramen ovale (PFO) closure, anticoagulation, and …

Background and Purpose—Patent foramen ovale (PFO) is significantly associated with
cryptogenic stroke (CS). However, even in patients with CS, a PFO can be an incidental …

tion by TCD does not necessarily imply the presence of a PFO. Any right-to-left shunt such
as that resulting from ventricular septal defect or intrapulmonary shunt may result in the …

Background Transcatheter closure of patent foramen ovale (PFO) has become an effective
therapeutic strategy for cryptogenic stroke (CS). The identification of high-risk PFO is …

Background In patients with patent foramen ovale (PFO)–associated stroke, the presence of
large shunt or atrial septal aneurysm (ASA) has been suggested to convey a high risk of …